These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27626176)

  • 1. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
    Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
    Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of the advanced HCC: A second revolution by using immunotherapy].
    Fartoux L; Rosmorduc O
    Biol Aujourdhui; 2018; 212(3-4):85-87. PubMed ID: 30973137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutics for advanced hepatocellular carcinoma: Recent advances, current dilemma, and future directions.
    Zhu J; Yin T; Xu Y; Lu XJ
    J Cell Physiol; 2019 Aug; 234(8):12122-12132. PubMed ID: 30644100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Trend of the Treatment of Advanced Hepatocellular Carcinoma: Combination of Immunotherapy and Targeted Therapy.
    Dong H; Zhang Z; Ni M; Xu X; Luo Y; Wang Y; Zhang H; Chen J
    Curr Treat Options Oncol; 2024 Oct; 25(10):1239-1256. PubMed ID: 39259476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
    Eggert T; Greten TF
    Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer treatments for advanced hepatocellular carcinoma.
    Song MJ; Bae SH
    Korean J Intern Med; 2014 Mar; 29(2):149-55. PubMed ID: 24648795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of advanced hepatocellular carcinoma : Novel agents and role of local therapy].
    Parisod L; Duran R; Denys A; Digklia A
    Rev Med Suisse; 2017 May; 13(563):1032-1034. PubMed ID: 28636293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality treatment involving radiotherapy for advanced liver-confined hepatocellular carcinoma.
    Yoon HI; Seong J
    Oncology; 2014; 87 Suppl 1():90-8. PubMed ID: 25427739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatocellular carcinoma.
    Giuliani F; Colucci G
    Oncology; 2009; 77 Suppl 1():43-9. PubMed ID: 20130431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
    Shimose S; Iwamoto H; Tanaka M; Niizeki T; Shirono T; Kajiwara A; Noda Y; Kamachi N; Okamura S; Nakano M; Kuromatsu R; Kawaguchi T; Koga H; Torimura T
    Oncology; 2021; 99(12):756-765. PubMed ID: 34518483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma: Review of Targeted and Immune Therapies.
    da Motta Girardi D; Correa TS; Crosara Teixeira M; Dos Santos Fernandes G
    J Gastrointest Cancer; 2018 Sep; 49(3):227-236. PubMed ID: 29806062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging targeted strategies in advanced hepatocellular carcinoma.
    Finn RS
    Semin Liver Dis; 2013 Feb; 33 Suppl 1():S11-9. PubMed ID: 23457035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
    Au JS; Frenette CT
    Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma review: current treatment, and evidence-based medicine.
    Raza A; Sood GK
    World J Gastroenterol; 2014 Apr; 20(15):4115-27. PubMed ID: 24764650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in non-surgical management of primary liver cancer.
    Chen X; Liu HP; Li M; Qiao L
    World J Gastroenterol; 2014 Nov; 20(44):16630-8. PubMed ID: 25469032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma.
    Xiang X; Zhong JH; Wang YY; You XM; Ma L; Xiang BD; Li LQ
    Clin Transl Oncol; 2017 Jul; 19(7):891-897. PubMed ID: 28160206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence and topics of chemotherapy for hepatocellular carcinoma].
    Ueshima K; Kudo M
    Nihon Shokakibyo Gakkai Zasshi; 2017; 114(9):1621-1628. PubMed ID: 28883291
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
    Chang Lee R; Tebbutt N
    Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug research and development and unmet needs for advanced-stage hepatocellular carcinoma].
    Zhou HB; Hu HP
    Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):306-311. PubMed ID: 38733184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.